Vivos Therapeutics expands AI platform deal with Greenway Health
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations
August 11, 2026 8:45 AM EDTGreenway analysis estimates AI-enabled automation in Nevada alone could create up to $9.0 million in potential annual value, including approximately $8.0 million from increased patient capacity and $1.0 million from revenue-cycle improvements
In addition, Vivos expects to save $1.8 million annually from Greenways recovery of an estimated 46,000+ employee hours, while creating capacity for nearly 30,000 additional patient visits
LITTLETON, Colo., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (Vivos or the Company) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on developing and commercializing innovative diagnostic and treatment... More
